1. Home
  2. CRCT vs ALLO Comparison

CRCT vs ALLO Comparison

Compare CRCT & ALLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cricut Inc.

CRCT

Cricut Inc.

HOLD

Current Price

$3.99

Market Cap

904.7M

Sector

Industrials

ML Signal

HOLD

Logo Allogene Therapeutics Inc.

ALLO

Allogene Therapeutics Inc.

HOLD

Current Price

$2.00

Market Cap

738.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRCT
ALLO
Founded
1969
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Wholesale Distributors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
904.7M
738.4M
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
CRCT
ALLO
Price
$3.99
$2.00
Analyst Decision
Strong Sell
Strong Buy
Analyst Count
1
15
Target Price
$3.00
$8.35
AVG Volume (30 Days)
464.0K
6.2M
Earning Date
05-05-2026
05-07-2026
Dividend Yield
22.20%
N/A
EPS Growth
20.69
34.09
EPS
0.10
N/A
Revenue
$708,780,000.00
N/A
Revenue This Year
$0.08
N/A
Revenue Next Year
$0.98
$142,416.42
P/E Ratio
$39.85
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.74
$0.99
52 Week High
$7.33
$4.46

Technical Indicators

Market Signals
Indicator
CRCT
ALLO
Relative Strength Index (RSI) 41.10 41.17
Support Level $3.82 $1.85
Resistance Level $4.68 $2.71
Average True Range (ATR) 0.20 0.14
MACD -0.03 -0.02
Stochastic Oscillator 16.05 28.18

Price Performance

Historical Comparison
CRCT
ALLO

About CRCT Cricut Inc.

Cricut Inc designs and builds a creativity platform that enables users to turn ideas into professional-looking handmade goods. With its connected machines, design apps and accessories, and materials, the users create everything from personalized birthday cards, mugs and T-shirts to large-scale interior decorations. It has two segments including the Platform segment which derives revenue from monthly and annual subscription fees, purchases of digital content, and a minimal amount of the revenue allocated to unspecified future upgrades and enhancements related to the essential software and access to the Company's cloud-based services and Products segment which derives revenue from the sale of its connected machine hardware, and sale of craft, DIY, home decor products and extensions.

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical stage immuno-oncology company pioneering the development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases. Its pipeline includes "off-the-shelf" T cell candidates designed to target cancer cells or eliminate autoreactive cells in patients with autoimmune disorders. Its three core programs are: Large B-Cell Lymphoma (LBCL), Autoimmune Disease (AID) and Renal Cell Carcinoma (RCC).

Share on Social Networks: